Atlas Advisors Australia acquires stake in Broadway Medical Centre

Atlas Advisors Australia

Leading wealth manager Atlas Advisors Australia has taken a significant stake in a key health asset, Broadway Medical Centre at Ellenbrook, Western Australia.

Atlas Advisors Australia is a co-investor in ASX-listed Elanor Investors Group’s Elanor Healthcare Real Estate Fund which purchased the property 150 Coolamon Boulevard, growing the portfolio to more than $201 million.

It is the fifth acquisition since the fund was established in March 2020.

Atlas Advisors Australia is a major shareholder in Elanor’s Burke Street Health Care Real Estate class which is comprised of two fully occupied A-Grade premises – the Princess Alexandra Hospital Burke Street Centre, in Brisbane, Queensland.

It also manages two other healthcare real estates in the Elanor Healthcare Real Estate Fund – a multi-tenanted medical office and day surgery at Spring Hill, Brisbane and multi-tenanted medical office and day surgery at Pacific Private, Southport, Gold Coast.

Executive Chairman of Atlas Advisors Australia, Guy Hedley said Broadway Medical Centre was another high-quality commercial healthcare acquisition with secure tenancies in an important health district.

The 1596 sqm building which houses the Broadway Medical Centre is fully leased with nine tenancies. Ellenbrook is about 30 kilometres north of Perth.

“Demand for private healthcare facilities including day and short-stay hospitals is increasing with more elective surgery shifting outside public hospital settings,” Mr Hedley said.

“Along with strong growth prospects, these assets also present further opportunities for expansion and development.”

Mr Hedley said healthcare was the at core of Atlas Advisors Australia commercial property interests.

“We are looking forward to further expanding into healthcare in partnership with expert fund managers Elanor Investors Group,” Mr Hedley said.

About Atlas Advisors Australia

Atlas Advisors Australia is a leading funds manager, operating between China and. With operations in Sydney and Melbourne in Australia and Hong Kong, we are able to support investors in all China and Australia locations.

/Public Release. This material comes from the originating organization/author(s)and may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).